AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Cefimoxy-CV 625 Tablet

Prescription Icon
Prescription Required

Marketer

Bkyula Biotech

Salt Composition

Amoxycillin (500mg) + Clavulanic Acid (125mg)

Overview Cefimoxy-CV 625 Tablet

Ceftriaxone 625mg tablets are a bacterial infection fighter, combating infections in various parts of the body. These include respiratory ailments like pneumonia, ear and sinus infections, urinary tract infections, and skin and soft tissue infections. It's ineffective against viral infections such as the common cold. For optimal absorption and minimized stomach discomfort, take Ceftriaxone 625mg with food, following your doctor's prescribed schedule for consistent dosing. The dosage varies depending on the infection; however, it's crucial to complete the full course of treatment, even if symptoms improve. Premature discontinuation can lead to recurring or intensified infection. Common side effects may include nausea, diarrhea, vomiting, oral or genital yeast infections, rashes, and vaginal inflammation. While usually mild, persistent or bothersome side effects warrant medical attention. Prior to commencing treatment, disclose any antibiotic allergies, liver or kidney issues, and all other medications you are currently using to your physician, as interactions are possible. This medication is typically considered safe for pregnant and breastfeeding individuals under a doctor's supervision.

Uses of Cefimoxy-CV 625 Tablet

Managing Bacterial Infections

Major Benefits of Cefimoxy-CV 625 Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Cefimoxy-CV 625 Tablet with a meal.

Common Side effects of Cefimoxy-CV 625 Tablet:

  • Vaginal inflammation
  • Mucocutaneous candidiasis
  • Vomiting
  • Nausea
  • Diarrhea
  • Skin rash
  • Red spots or bumps
  • Fungal infection

How to use Cefimoxy-CV 625 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cefimoxy-CV 625 Tablets should be administered with a meal.

How Cefimoxy-CV 625 Tablet works:

Cefimoxy-CV 625 Tablets contain amoxicillin, an antibiotic, and clavulanic acid, a beta-lactamase inhibitor. Amoxicillin combats bacterial growth by disrupting the formation of their protective cell walls. Clavulanic acid counters bacterial resistance mechanisms, thereby bolstering amoxicillin's effectiveness.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions from concurrent use of Cefimoxy-CV 625 Tablet and alcohol.

PregnancyPregnancySAFE IF PRESCRIBED

Pregnancy use of Cefimoxy-CV 625 Tablet is generally regarded as safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human studies are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Cefimoxy-CV 625 tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Cefimoxy-CV 625 Tablet side effects, including allergic reactions, dizziness, or seizures.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Cefimoxy-CV 625 Tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. This medication is contraindicated for individuals with severely compromised renal function.

LiverLiverCAUTION

Patients with liver impairment should use Cefimoxy-CV 625 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Liver function should be regularly assessed during treatment.

What if you forget to take Cefimoxy-CV 625 Tablet :

Should you forget a Cefimoxy-CV 625 Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Cefimoxy-CV 625 Tablet

LabelValue
Potential for Dependence None.
Type of Medication Drugs against infection

FAQs on Cefimoxy-CV 625 Tablet

Amoxycillin and clavulanic acid, combined as Cefimoxy-CV 625 Tablet, effectively combats various bacterial infections. These include, but aren't limited to, tonsillitis, sinusitis, middle ear infections, respiratory illnesses, urinary tract infections, skin boils and abscesses, cellulitis, infected wounds, bone infections, and oral infections. Its mechanism of action involves eliminating the bacteria responsible for these infections.
Cefimoxy-CV 625 tablets are safe under a physician's guidance. Nevertheless, some individuals might experience typical side effects such as nausea, vomiting, diarrhea, rash, or allergic reactions, alongside less frequent or infrequent adverse effects. Promptly consult your doctor if any issues persist throughout your treatment.
Patients with documented penicillin hypersensitivity or an allergy to any Cefimoxy-CV 625 Tablet component should avoid its use. Individuals with a history of hepatic impairment should not take this medication. Always disclose any medication allergies to your physician.
Cefimoxy-CV 625 Tablet may reduce the effectiveness of oral contraceptives. Therefore, discuss alternative birth control options, such as condoms, diaphragms, or spermicides, with your physician while using this medication.
Exceeding the prescribed dosage of Cefimoxy-CV 625 Tablets elevates the likelihood of adverse reactions. Therapeutic efficacy with Cefimoxy-CV 625 Tablets requires sufficient time to fully combat the infection. Should your symptoms worsen, seek immediate medical attention for reassessment.
Retain this medication in its original, sealed container. Follow the storage directions provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Discontinue Cefimoxy-CV 625 Tablet only upon completion of the prescribed treatment regimen. Even with symptom improvement, ceasing medication prematurely might leave the infection unresolved. Therefore, continued use is crucial, as therapeutic benefits may persist despite feeling better.
Cefimoxy-CV 625 Tablets may trigger allergic responses. Individuals with documented penicillin allergies should avoid this medication. Seek immediate medical attention if you experience symptoms such as skin rashes, respiratory distress, or facial, lip, tongue, or throat swelling.
Cefimoxy-CV 625 Tablet use may result in diarrhea. This antibiotic eliminates harmful bacteria; however, it can also impact beneficial gut bacteria, leading to diarrhea. If diarrhea occurs, increase fluid intake. Persistent diarrhea or dehydration symptoms (reduced urination, dark, strong-smelling urine) warrant immediate medical attention. Avoid self-medicating without consulting a physician.
Cefimoxy-CV 625 Tablets are ineffective against viral illnesses such as influenza or the common cold. Seek professional medical advice; self-treating is inadvisable.
Cefimoxy-CV 625 Tablets are not associated with drowsiness. Report any drowsiness to your physician immediately.
Cefimoxy-CV 625 Tablet
103
MRP 120
14% off